Nadeem Sarwar Selected Research

Coronary Disease (Coronary Heart Disease)

3/2012	Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies.
5/2010	Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.
3/2010	NT-proBNP is associated with coronary heart disease risk in healthy older women but fails to enhance prediction beyond established risk factors: results from the British Women's Heart and Health Study.
8/2009	Triglycerides and coronary heart disease: have recent insights yielded conclusive answers?
1/2009	Leptin and coronary heart disease: prospective study and systematic review.
12/2008	Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis.
6/2008	Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk.
4/2008	Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.
10/2007	Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies.
1/2007	Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nadeem Sarwar Research Topics

Disease

11	Coronary Disease (Coronary Heart Disease) 03/2012 - 08/2006
6	Cardiovascular Diseases (Cardiovascular Disease) 03/2014 - 12/2009
5	Myocardial Infarction 01/2009 - 08/2006
3	Inflammation (Inflammations) 10/2012 - 03/2011
3	Vascular Diseases (Vascular Disease) 09/2010 - 11/2009
2	Bites and Stings (Sting) 01/2022 - 01/2021
1	Neoplasms (Cancer) 01/2022
1	Non-Muscle Invasive Bladder Neoplasms 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 07/2015
1	Diabetes Mellitus 03/2011
1	Chronic Renal Insufficiency 09/2010
1	Hypertension (High Blood Pressure) 03/2010
1	Left Ventricular Dysfunction 12/2009
1	Ischemic Stroke 11/2009
1	Coronary Stenosis (Coronary Artery Stenosis) 12/2008
1	Type 2 Diabetes Mellitus (MODY) 08/2006

Drug/Important Bio-Agent (IBA)

8	LipidsIBA 06/2012 - 06/2008
5	Triglycerides (Triacylglycerol)IBA 05/2010 - 01/2007
4	HDL CholesterolIBA 10/2012 - 12/2008
3	Biomarkers (Surrogate Marker)IBA 07/2015 - 03/2012
2	InterferonsIBA 01/2022 - 01/2021
2	CytokinesIBA 01/2022 - 04/2008
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2010
2	CholesterolIBA 10/2012 - 06/2012
2	ApolipoproteinsIBA 06/2012 - 11/2009
2	Glucose (Dextrose)FDA LinkGeneric 03/2011 - 03/2010
2	Lipoproteins (Lipoprotein)IBA 05/2010 - 12/2008
2	pro-brain natriuretic peptide (1-76)IBA 03/2010 - 12/2009
1	Nucleic AcidsIBA 01/2021
1	methylated bovine serum albumin (MBSA)IBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2014
1	C-Reactive ProteinIBA 10/2012
1	Fibrinogen (Factor I)FDA Link 10/2012
1	Lipoprotein(a)IBA 06/2012
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 06/2012
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2012
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 03/2012
1	Apolipoprotein A-VIBA 05/2010
1	P-2 (P 2)IBA 05/2010
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2010
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2009
1	Peptides (Polypeptides)IBA 12/2009
1	LeptinIBA 01/2009
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 12/2008
1	EnzymesIBA 12/2008
1	Cholesterol Ester Transfer ProteinsIBA 06/2008
1	ORALIT (ORS)IBA 06/2008
1	Interleukin-6 (Interleukin 6)IBA 04/2008
1	Insulin (Novolin)FDA Link 10/2007
1	AdiponectinIBA 08/2006

Therapy/Procedure

1	Therapeutics 01/2022
1	Intravesical Administration 01/2022